T 0832/18 (Method for determining responsiveness of cancer to treatments targeting EGFR/GENERAL HOSPITAL CORPORATION & DANA-FARBER CANCER INSTITUTE) of 09.12.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T083218.20241209
- Date of decision
- 9 December 2024
- Case number
- T 0832/18
- Online on
- 30 October 2025
- Petition for review of
- -
- Application number
- 05757467.5
- IPC class
- C12Q 1/68C07H 21/04
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHOD TO DETERMINE RESPONSIVENESS OF CANCER TO EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING TREATMENTS
- Applicant name
- THE GENERAL HOSPITAL CORPORATION
Dana-Farber Cancer Institute, Inc. - Opponent name
- James Poole Limited
Strawman Limited - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83
- Keywords
- Main request and first to third auxiliary requests and P0 to P3 - sufficiency of disclosure (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.